Free Trial

Amphenol (APH) Financials

Amphenol logo
$127.72 -0.31 (-0.24%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$127.70 -0.02 (-0.01%)
As of 09:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Amphenol

Annual Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
764 823 651 1,205 1,155 1,203 1,580 1,902 1,928 2,424 4,270
Consolidated Net Income / (Loss)
772 833 661 1,217 1,164 1,213 1,591 1,917 1,946 2,442 4,305
Net Income / (Loss) Continuing Operations
772 833 661 1,217 1,164 1,213 1,580 1,917 1,946 2,442 4,305
Total Pre-Tax Income
1,053 1,141 1,352 1,588 1,496 1,527 1,989 2,467 2,455 3,012 5,601
Total Operating Income
1,105 1,205 1,428 1,687 1,619 1,638 2,105 2,586 2,560 3,157 5,869
Total Gross Profit
1,780 2,040 2,310 2,655 2,616 2,664 3,402 4,028 4,084 5,140 8,518
Total Revenue
5,569 6,286 7,011 8,202 8,225 8,599 10,876 12,623 12,555 15,223 23,095
Operating Revenue
5,569 6,286 7,011 8,202 8,225 8,599 10,876 12,623 12,555 15,223 23,095
Total Cost of Revenue
3,789 4,246 4,701 5,547 5,609 5,935 7,475 8,595 8,471 10,083 14,577
Operating Cost of Revenue
3,789 4,246 4,701 5,547 5,609 5,935 7,475 8,595 8,471 10,083 14,577
Total Operating Expenses
675 835 882 968 997 1,026 1,297 1,442 1,525 1,983 2,649
Selling, General & Admin Expense
669 798 878 960 971 1,014 1,226 1,421 1,490 1,855 2,546
Other Operating Expenses / (Income)
- - - - - - - 22 35 - 103
Total Other Income / (Expense), net
-52 -64 -75 -99 -123 -112 -116 -118 -105 -145 -268
Interest Expense
68 73 92 102 132 115 116 128 140 217 368
Other Income / (Expense), net
16 8.50 17 3.20 8.60 3.60 -0.40 10 35 72 100
Income Tax Expense
281 309 692 372 332 313 409 551 509 570 1,295
Net Income / (Loss) Attributable to Noncontrolling Interest
8.80 9.70 10 12 9.00 9.90 11 15 18 18 35
Basic Earnings per Share
$2.47 $2.67 $2.13 $4.00 $1.94 $2.02 $2.66 $1.60 $1.62 $2.01 $3.51
Weighted Average Basic Shares Outstanding
309.10M 308.30M 305.70M 301.20M 595M 596.10M 597.90M 1.19B 1.19B 1.20B 1.22B
Diluted Earnings per Share
$2.41 $2.61 $2.06 $3.85 $1.88 $1.96 $2.54 $1.53 $1.55 $1.92 $3.34
Weighted Average Diluted Shares Outstanding
316.50M 315.20M 316.50M 312.60M 615.90M 615M 625.50M 1.24B 1.24B 1.26B 1.28B
Weighted Average Basic & Diluted Shares Outstanding
309.10M 307.66M 305.40M 301.30M 298.10M 299.58M 598.94M 594.60M 599.85M 1.21B 1.23B
Cash Dividends to Common per Share
$0.53 $0.58 $0.70 $0.88 $0.48 $0.52 $0.64 $0.41 $0.43 $0.55 $0.75

Quarterly Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
514 514 549 525 604 746 738 1,091 1,246 1,196 933
Consolidated Net Income / (Loss)
518 519 552 529 609 752 744 1,101 1,255 1,205 943
Net Income / (Loss) Continuing Operations
518 519 552 529 609 752 744 1,101 1,255 1,205 943
Total Pre-Tax Income
634 666 663 664 775 910 963 1,348 1,641 1,649 1,646
Total Operating Income
658 690 685 699 820 954 1,025 1,419 1,702 1,723 1,832
Total Gross Profit
1,049 1,101 1,089 1,213 1,357 1,481 1,644 2,053 2,359 2,461 2,800
Total Revenue
3,199 3,328 3,256 3,610 4,039 4,318 4,811 5,650 6,194 6,439 7,620
Operating Revenue
3,199 3,328 3,256 3,610 4,039 4,318 4,811 5,650 6,194 6,439 7,620
Total Cost of Revenue
2,151 2,227 2,167 2,397 2,682 2,837 3,167 3,597 3,835 3,978 4,820
Operating Cost of Revenue
2,151 2,227 2,167 2,397 2,682 2,837 3,167 3,597 3,835 3,978 4,820
Total Operating Expenses
391 410 404 514 537 527 619 635 657 738 968
Selling, General & Admin Expense
382 394 404 444 492 515 575 623 657 691 852
Other Operating Expenses / (Income)
9.00 - - 70 - - - - 0.00 - 117
Total Other Income / (Expense), net
-24 -25 -22 -35 -45 -43 -62 -71 -61 -74 -186
Interest Expense
34 35 38 56 56 67 77 81 81 130 208
Other Income / (Expense), net
9.20 10 16 21 11 24 15 10 19 56 22
Income Tax Expense
115 146 111 135 166 158 219 247 386 444 702
Net Income / (Loss) Attributable to Noncontrolling Interest
4.40 4.80 3.30 3.90 4.50 5.90 6.40 9.50 9.40 9.70 10
Basic Earnings per Share
$0.43 $0.43 $0.46 $0.44 $0.50 $0.62 $0.61 $0.90 $1.02 $0.98 $0.76
Weighted Average Basic Shares Outstanding
1.20B 1.19B 1.20B 1.20B 1.20B 1.20B 1.21B 1.22B 1.22B 1.22B 1.23B
Diluted Earnings per Share
$0.41 $0.43 $0.44 $0.41 $0.48 $0.62 $0.58 $0.86 $0.97 $0.98 $0.72
Weighted Average Diluted Shares Outstanding
1.24B 1.24B 1.26B 1.26B 1.27B 1.26B 1.27B 1.27B 1.28B 1.28B 1.29B
Weighted Average Basic & Diluted Shares Outstanding
598.31M 599.85M 600.60M 1.20B 1.21B 1.21B 1.21B 1.22B 1.22B 1.23B 1.23B
Cash Dividends to Common per Share
- $0.12 - $0.11 - $0.18 $0.17 $0.17 - $0.17 $0.25

Annual Cash Flow Statements for Amphenol

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
768 -703 624 -399 -388 811 -505 176 102 1,842 7,814
Net Cash From Operating Activities
1,031 1,078 1,144 1,113 1,502 1,592 1,540 2,175 2,529 2,815 5,375
Net Cash From Continuing Operating Activities
1,031 1,078 1,144 1,113 1,502 1,592 1,524 2,175 2,529 2,815 5,375
Net Income / (Loss) Continuing Operations
772 833 661 1,217 1,164 1,213 1,580 1,917 1,946 2,442 4,305
Consolidated Net Income / (Loss)
772 833 661 1,217 1,164 - 1,580 1,917 1,946 2,442 4,305
Depreciation Expense
172 217 227 300 312 308 396 393 406 573 922
Non-Cash Adjustments To Reconcile Net Income
28 3.20 50 56 77 71 53 90 94 110 135
Changes in Operating Assets and Liabilities, net
59 25 207 -460 -51 0.10 -491 -225 83 -309 12
Net Cash From Investing Activities
-27 -1,613 -380 -442 -1,229 -334 -1,888 -731 -1,394 -2,649 -5,082
Net Cash From Continuing Investing Activities
-27 -1,613 -380 -442 -1,229 -334 -2,604 -731 -1,394 -2,649 -5,082
Purchase of Property, Plant & Equipment
-172 -191 -227 -311 -295 -277 -360 -384 -373 -665 -997
Acquisitions
-200 -1,305 -266 -159 -937 -50 -2,225 -288 -970 -2,156 -3,819
Purchase of Investments
-135 -232 -40 -45 -65 -142 -165 -309 -306 -26 -309
Sale of Property, Plant & Equipment
8.70 7.10 4.10 5.00 7.40 13 3.70 5.60 4.00 7.80 15
Sale and/or Maturity of Investments
471 109 148 67 62 123 156 228 246 190 28
Other Investing Activities, net
- - - 0.00 0.00 -0.60 -14 17 4.90 1.90 0.00
Net Cash From Financing Activities
-180 -134 -140 -1,070 -648 -517 -145 -1,197 -1,012 1,730 7,423
Net Cash From Continuing Financing Activities
-180 -134 -140 -1,070 -648 -517 -145 -1,197 -1,012 1,730 7,423
Repayment of Debt
-218 180 -380 -565 -1,140 -2,367 -126 -215 -651 -391 -490
Repurchase of Common Equity
-249 -326 -618 -935 -602 -641 -662 -731 -585 -689 -665
Payment of Dividends
-165 -180 -229 -272 -323 -313 -366 -487 -525 -628 -808
Issuance of Debt
371 0.00 903 572 1,170 2,510 752 51 355 2,991 8,922
Other Financing Activities, net
81 192 184 131 246 295 256 185 393 447 465
Effect of Exchange Rate Changes
-55 -34 - - - 69 - -71 -21 -54 98
Cash Interest Paid
64 69 84 94 117 105 112 124 129 180 288
Cash Income Taxes Paid
251 247 325 393 408 337 446 478 560 650 1,084

Quarterly Cash Flow Statements for Amphenol

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
156 -6.50 382 -605 311 1,754 -1,660 1,550 592 7,331 -7,003
Net Cash From Operating Activities
618 842 600 664 704 847 765 1,417 1,471 1,722 1,122
Net Cash From Continuing Operating Activities
612 842 600 664 704 847 765 1,417 1,471 1,722 1,122
Net Income / (Loss) Continuing Operations
518 519 552 529 609 752 744 1,101 1,255 1,205 943
Consolidated Net Income / (Loss)
518 519 552 529 609 752 744 1,101 1,255 1,205 943
Depreciation Expense
101 115 104 124 201 144 236 209 228 249 486
Non-Cash Adjustments To Reconcile Net Income
32 27 24 27 30 30 27 31 37 41 34
Changes in Operating Assets and Liabilities, net
-40 181 -80 -15 -136 -78 -242 75 -49 227 -342
Net Cash From Investing Activities
-329 -689 -17 -2,179 -203 -250 -2,353 -612 -614 -1,504 -11,031
Net Cash From Continuing Investing Activities
-329 -689 -17 -2,179 -203 -250 -2,353 -612 -614 -1,504 -11,031
Purchase of Property, Plant & Equipment
-75 -105 -94 -141 -230 -200 -189 -297 -257 -254 -292
Acquisitions
-179 -678 0.00 -2,100 - -57 -2,172 -311 -289 -1,046 -10,592
Purchase of Investments
-80 -87 -12 -1.50 -7.30 -5.50 -3.10 -9.50 -75 -222 -233
Sale of Property, Plant & Equipment
0.50 1.90 0.50 4.90 1.70 0.70 4.10 1.60 1.90 7.20 1.30
Sale and/or Maturity of Investments
4.00 179 88 58 36 8.00 7.20 4.40 4.70 11 84
Other Investing Activities, net
-0.10 - 1.10 0.80 -2.80 2.80 0.00 - - - 0.00
Net Cash From Financing Activities
-118 -190 -176 920 -228 1,214 -89 701 -266 7,077 2,898
Net Cash From Continuing Financing Activities
-118 -190 -176 920 -228 1,214 -89 701 -266 7,077 2,898
Repayment of Debt
-636 -5.40 -4.00 -362 -1.30 -24 239 -648 -20 -61 -358
Repurchase of Common Equity
-149 -115 -154 -190 -176 -169 -181 -160 -153 -171 -178
Payment of Dividends
-127 -142 -132 -150 -136 -211 -200 -202 -205 -202 -307
Issuance of Debt
635 0.90 0.00 1,500 - 1,491 0.00 1,430 - 7,492 3,645
Other Financing Activities, net
159 71 113 121 86 127 53 281 112 20 96
Effect of Exchange Rate Changes
- 31 -24 -9.60 37 - 17 - - 35 8.40
Cash Interest Paid
29 40 33 38 41 67 52 88 50 99 120
Cash Income Taxes Paid
99 137 130 229 157 134 168 335 325 257 348

Annual Balance Sheets for Amphenol

This table presents Amphenol's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
7,458 8,499 10,004 10,045 10,816 12,327 14,678 15,326 16,526 21,440 36,237
Total Current Assets
3,850 3,591 4,656 4,572 4,211 5,491 5,958 6,479 6,835 9,686 20,267
Cash & Equivalents
1,737 1,035 1,719 1,279 891 1,702 1,197 1,373 1,475 3,317 11,131
Short-Term Investments
23 139 35 12 17 36 44 61 185 18 304
Accounts Receivable
1,105 1,349 1,599 1,792 1,736 1,952 2,455 2,631 2,618 3,288 4,717
Inventories, net
852 929 1,107 1,234 1,310 1,462 1,894 2,094 2,167 2,546 3,425
Prepaid Expenses
- - - 254 256 339 368 320 390 517 691
Plant, Property, & Equipment, net
610 711 817 876 999 1,055 1,175 1,204 1,315 1,712 2,306
Total Noncurrent Assets
2,999 4,196 4,531 4,598 5,605 5,782 7,545 7,643 8,376 10,042 13,664
Goodwill
2,693 3,679 4,043 4,103 4,867 5,032 6,377 6,446 7,092 8,236 10,575
Intangible Assets
306 517 489 398 442 398 757 734 835 1,225 2,241
Other Noncurrent Operating Assets
- - - 96 296 352 411 463 449 581 847
Total Liabilities & Shareholders' Equity
7,458 8,499 10,004 10,045 10,816 12,327 14,678 15,326 16,526 21,440 36,237
Total Liabilities
4,180 4,776 5,961 5,981 6,219 6,875 8,299 8,232 8,100 11,584 22,727
Total Current Liabilities
1,008 1,635 1,579 2,451 2,133 2,304 2,447 2,676 3,153 4,084 6,803
Short-Term Debt
0.30 375 1.10 764 403 230 4.00 2.70 354 402 937
Accounts Payable
588 678 876 891 867 1,121 1,312 1,309 1,351 1,819 2,662
Dividends Payable
43 49 58 69 74 87 120 125 132 200 307
Current Deferred & Payable Income Tax Liabilities
82 125 154 204 128 113 89 170 166 199 483
Current Employee Benefit Liabilities
106 132 152 157 172 291 366 417 413 530 768
Other Current Liabilities
190 276 339 367 489 463 556 653 738 934 1,646
Total Noncurrent Liabilities
3,172 3,140 4,381 3,529 4,087 4,571 5,852 5,556 4,947 7,500 15,924
Long-Term Debt
2,813 2,636 3,542 2,806 3,203 3,636 4,796 4,575 3,984 6,484 14,565
Noncurrent Deferred & Payable Income Tax Liabilities
- 78 241 256 260 299 424 410 367 377 433
Noncurrent Employee Benefit Liabilities
263 288 272 190 199 229 193 128 143 130 138
Other Noncurrent Operating Liabilities
96 139 326 277 424 407 439 443 454 509 789
Redeemable Noncontrolling Interest
- - - - - - 19 21 31 8.70 9.30
Total Equity & Noncontrolling Interests
3,278 3,723 4,043 4,064 4,596 5,452 6,360 7,074 8,396 9,847 13,500
Total Preferred & Common Equity
3,239 3,675 3,990 4,017 4,530 5,385 6,302 7,016 8,347 9,792 13,413
Total Common Equity
3,239 3,675 3,990 4,017 4,530 5,385 6,302 7,016 8,347 9,792 13,413
Common Stock
784 1,021 1,249 1,434 1,684 2,069 2,410 2,651 3,102 3,603 4,234
Retained Earnings
2,804 3,123 2,942 3,029 3,348 3,705 4,279 4,979 5,921 7,105 9,854
Treasury Stock
- - 0.00 -55 - -111 -100 -80 -143 -200 -196
Accumulated Other Comprehensive Income / (Loss)
-350 -469 -201 -390 -431 -278 -287 -535 -534 -716 -480
Noncontrolling Interest
40 48 54 47 66 67 58 58 49 55 87

Quarterly Balance Sheets for Amphenol

This table presents Amphenol's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
15,238 15,759 16,526 16,723 18,587 19,586 21,440 22,902 25,668 27,143 42,134
Total Current Assets
6,321 6,773 6,835 7,042 6,972 7,773 9,686 9,133 11,299 12,384 15,384
Cash & Equivalents
1,325 1,482 1,475 1,857 1,253 1,563 3,317 1,657 3,207 3,799 4,128
Short-Term Investments
178 253 185 106 50 20 18 15 19 89 455
Accounts Receivable
2,444 2,571 2,618 2,501 2,856 3,130 3,288 3,920 4,271 4,544 5,873
Inventories, net
1,998 2,099 2,167 2,153 2,399 2,579 2,546 2,906 3,137 3,300 4,087
Prepaid Expenses
377 369 390 424 415 480 517 635 664 652 841
Plant, Property, & Equipment, net
1,259 1,247 1,315 1,312 1,534 1,671 1,712 1,855 2,054 2,142 2,689
Total Noncurrent Assets
7,658 7,739 8,376 8,369 10,081 10,142 10,042 11,914 12,316 12,618 24,062
Goodwill
6,519 6,575 7,092 7,101 8,262 8,352 8,236 9,274 9,651 9,869 17,543
Intangible Assets
724 744 835 785 1,309 1,247 1,225 2,002 1,989 1,982 5,401
Other Noncurrent Operating Assets
416 420 449 483 511 543 581 638 675 767 1,118
Total Liabilities & Shareholders' Equity
15,238 15,759 16,526 16,723 18,587 19,586 21,440 22,902 25,668 27,143 42,134
Total Liabilities
7,646 7,821 8,100 7,958 9,536 10,059 11,584 12,530 14,069 14,536 28,042
Total Current Liabilities
2,710 2,909 3,153 3,423 3,456 3,902 4,084 4,591 5,604 5,984 8,975
Short-Term Debt
352 356 354 753 404 403 402 351 937 938 2,110
Accounts Payable
1,117 1,249 1,351 1,265 1,521 1,763 1,819 2,142 2,373 2,462 3,182
Dividends Payable
125 126 132 132 132 199 200 200 201 202 307
Current Deferred & Payable Income Tax Liabilities
100 114 166 151 104 124 199 260 193 253 657
Current Employee Benefit Liabilities
336 361 413 351 423 480 530 475 603 689 676
Other Current Liabilities
680 704 738 772 870 932 934 1,163 1,297 1,441 2,044
Total Noncurrent Liabilities
4,936 4,912 4,947 4,535 6,081 6,157 7,500 7,939 8,465 8,552 19,068
Long-Term Debt
3,967 3,936 3,984 3,557 5,035 5,081 6,484 6,816 7,126 7,130 16,639
Noncurrent Deferred & Payable Income Tax Liabilities
407 413 367 371 446 440 377 387 369 378 1,270
Noncurrent Employee Benefit Liabilities
133 129 143 142 141 147 130 134 149 150 154
Other Noncurrent Operating Liabilities
428 433 454 465 458 489 509 602 822 895 1,005
Redeemable Noncontrolling Interest
21 22 31 31 20 21 8.70 9.30 10 10 9.10
Total Equity & Noncontrolling Interests
7,571 7,917 8,396 8,734 9,031 9,506 9,847 10,363 11,590 12,597 14,082
Total Preferred & Common Equity
7,514 7,857 8,347 8,682 8,980 9,453 9,792 10,301 11,519 12,520 13,977
Total Common Equity
7,514 7,857 8,347 8,682 8,980 9,453 9,792 10,301 11,519 12,520 13,977
Common Stock
2,861 3,016 3,102 3,225 3,350 3,459 3,603 3,673 3,959 4,094 4,349
Retained Earnings
5,295 5,670 5,921 6,164 6,352 6,751 7,105 7,446 8,135 9,155 10,432
Treasury Stock
-50 -171 -143 -104 -74 -237 -200 -174 -105 -221 -310
Accumulated Other Comprehensive Income / (Loss)
-593 -658 -534 -603 -649 -520 -716 -644 -470 -508 -494
Noncontrolling Interest
57 60 49 52 51 54 55 62 70 76 106

Annual Metrics And Ratios for Amphenol

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.18% 12.89% 11.53% 16.98% 0.29% 4.54% 26.48% 16.06% -0.54% 21.25% 51.71%
EBITDA Growth
5.87% 10.68% 16.83% 19.04% -2.51% 0.53% 28.21% 19.53% 0.40% 26.68% 81.27%
EBIT Growth
6.48% 8.26% 19.03% 16.99% -3.69% 0.87% 28.18% 23.33% -0.06% 24.46% 84.85%
NOPAT Growth
6.51% 8.51% -20.69% 85.30% -2.51% 3.35% 28.42% 20.13% 0.98% 26.16% 76.28%
Net Income Growth
7.98% 7.81% -20.65% 84.18% -4.35% 4.24% 31.11% 20.49% 1.50% 25.50% 76.33%
EPS Growth
9.05% 8.30% -21.07% 86.89% -4.35% 4.24% 29.59% 20.49% 1.50% 23.87% 73.96%
Operating Cash Flow Growth
12.87% 4.57% 6.18% -2.75% 35.01% 5.97% -3.26% 41.20% 16.28% 11.31% 90.95%
Free Cash Flow Firm Growth
165.43% -148.16% 217.17% 84.89% -60.67% 231.12% -171.54% 337.24% -32.16% -83.72% 24.02%
Invested Capital Growth
1.66% 28.24% 5.00% 8.85% 14.92% 4.05% 31.18% 3.03% 8.42% 21.10% 31.44%
Revenue Q/Q Growth
0.07% 3.64% 4.36% 3.54% -0.89% 3.30% 5.85% 1.71% 0.71% 6.96% 10.11%
EBITDA Q/Q Growth
0.18% 4.35% 4.08% 5.39% -2.80% 3.78% 5.72% 2.18% 1.27% 8.74% 15.15%
EBIT Q/Q Growth
0.80% 4.28% 4.39% 3.35% -1.65% 3.64% 5.21% 3.04% 1.21% 9.38% 15.51%
NOPAT Q/Q Growth
0.81% 4.39% -33.75% 57.12% -1.49% 3.13% 6.29% 2.92% 0.01% 10.81% 11.66%
Net Income Q/Q Growth
1.02% 4.49% -33.90% 56.98% -1.71% 3.34% 6.56% 2.84% 1.18% 11.42% 11.77%
EPS Q/Q Growth
-1.63% 2.35% -36.42% 51.57% -1.71% 3.34% 2.42% 2.84% 1.18% 6.67% 6.71%
Operating Cash Flow Q/Q Growth
7.35% 2.53% 7.41% -4.27% 3.15% 1.07% 1.96% 12.10% 5.71% 0.19% 19.45%
Free Cash Flow Firm Q/Q Growth
5.45% 17.44% -26.60% 10.18% -22.82% 3.35% -945.22% 97.32% -31.02% 127.07% -65.63%
Invested Capital Q/Q Growth
-2.35% -2.50% -5.58% 0.80% 1.67% 1.70% 9.55% 0.91% 5.77% -0.15% 5.28%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
31.96% 32.45% 32.95% 32.37% 31.80% 30.98% 31.28% 31.91% 32.53% 33.76% 36.88%
EBITDA Margin
23.21% 22.76% 23.84% 24.26% 23.58% 22.68% 22.99% 23.68% 23.90% 24.97% 29.84%
Operating Margin
19.84% 19.17% 20.36% 20.57% 19.69% 19.05% 19.35% 20.48% 20.39% 20.74% 25.41%
EBIT Margin
20.13% 19.31% 20.61% 20.61% 19.79% 19.10% 19.35% 20.56% 20.66% 21.21% 25.84%
Profit (Net Income) Margin
13.87% 13.24% 9.42% 14.84% 14.15% 14.11% 14.63% 15.19% 15.50% 16.04% 18.64%
Tax Burden Percent
73.36% 72.96% 48.85% 76.61% 77.81% 79.48% 79.97% 77.69% 79.25% 81.07% 76.87%
Interest Burden Percent
93.91% 94.02% 93.61% 93.98% 91.90% 92.97% 94.51% 95.05% 94.62% 93.28% 93.84%
Effective Tax Rate
26.64% 27.04% 51.15% 23.39% 22.19% 20.52% 20.57% 22.32% 20.75% 18.93% 23.13%
Return on Invested Capital (ROIC)
18.68% 17.61% 12.13% 21.01% 18.29% 17.32% 18.87% 19.67% 18.78% 20.60% 28.65%
ROIC Less NNEP Spread (ROIC-NNEP)
15.58% 14.48% 10.16% 17.41% 14.54% 13.76% 16.11% 17.03% 16.05% 17.02% 23.58%
Return on Net Nonoperating Assets (RNNOA)
6.17% 6.17% 4.89% 9.01% 8.60% 6.83% 8.02% 8.78% 6.29% 6.11% 8.20%
Return on Equity (ROE)
24.85% 23.78% 17.01% 30.02% 26.88% 24.15% 26.89% 28.45% 25.07% 26.71% 36.85%
Cash Return on Invested Capital (CROIC)
17.03% -7.13% 7.25% 12.53% 4.40% 13.35% -8.10% 16.69% 10.70% 1.51% 1.48%
Operating Return on Assets (OROA)
15.52% 15.21% 15.62% 16.86% 15.61% 14.19% 15.59% 17.30% 16.29% 17.01% 20.70%
Return on Assets (ROA)
10.69% 10.44% 7.14% 12.14% 11.16% 10.49% 11.78% 12.78% 12.22% 12.86% 14.93%
Return on Common Equity (ROCE)
24.57% 23.48% 16.79% 29.65% 26.53% 23.83% 26.56% 28.12% 24.81% 26.50% 36.60%
Return on Equity Simple (ROE_SIMPLE)
23.85% 22.66% 16.56% 30.29% 25.69% 22.53% 25.24% 27.32% 23.31% 24.93% 0.00%
Net Operating Profit after Tax (NOPAT)
810 879 697 1,292 1,260 1,302 1,672 2,009 2,029 2,559 4,511
NOPAT Margin
14.55% 13.99% 9.95% 15.76% 15.32% 15.14% 15.37% 15.91% 16.16% 16.81% 19.53%
Net Nonoperating Expense Percent (NNEP)
3.09% 3.14% 1.97% 3.60% 3.75% 3.56% 2.76% 2.65% 2.73% 3.58% 5.07%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 17.24% 15.93% 15.29% 15.55%
Cost of Revenue to Revenue
68.04% 67.55% 67.05% 67.63% 68.20% 69.02% 68.72% 68.09% 67.47% 66.24% 63.12%
SG&A Expenses to Revenue
12.02% 12.70% 12.53% 11.70% 11.81% 11.79% 11.28% 11.26% 11.87% 12.19% 11.02%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.12% 13.28% 12.58% 11.80% 12.12% 11.93% 11.92% 11.43% 12.14% 13.03% 11.47%
Earnings before Interest and Taxes (EBIT)
1,121 1,214 1,445 1,690 1,628 1,642 2,105 2,596 2,594 3,229 5,969
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,293 1,431 1,672 1,990 1,940 1,950 2,500 2,989 3,001 3,801 6,891
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.58 5.25 6.31 5.76 6.78 7.02 8.10 6.34 7.05 8.55 12.33
Price to Tangible Book Value (P/TBV)
61.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 140.27 253.19 277.41
Price to Revenue (P/Rev)
2.66 3.07 3.59 2.82 3.73 4.40 4.69 3.52 4.68 5.50 7.16
Price to Earnings (P/E)
19.43 23.43 38.67 19.20 26.59 31.43 32.29 23.38 30.51 34.54 38.74
Dividend Yield
1.10% 0.93% 0.85% 1.15% 0.93% 0.82% 0.74% 1.08% 0.86% 0.79% 0.55%
Earnings Yield
5.15% 4.27% 2.59% 5.21% 3.76% 3.18% 3.10% 4.28% 3.28% 2.90% 2.58%
Enterprise Value to Invested Capital (EV/IC)
3.64 3.77 4.58 3.97 4.54 5.22 5.43 4.60 5.48 6.42 9.48
Enterprise Value to Revenue (EV/Rev)
2.86 3.37 3.85 3.10 4.07 4.65 5.03 3.78 4.90 5.74 7.34
Enterprise Value to EBITDA (EV/EBITDA)
12.32 14.80 16.15 12.79 17.25 20.52 21.86 15.96 20.52 22.98 24.61
Enterprise Value to EBIT (EV/EBIT)
14.21 17.44 18.69 15.06 20.56 24.37 25.97 18.38 23.73 27.05 28.41
Enterprise Value to NOPAT (EV/NOPAT)
19.66 24.07 38.71 19.70 26.57 30.73 32.69 23.75 30.35 34.13 37.59
Enterprise Value to Operating Cash Flow (EV/OCF)
15.46 19.64 23.60 22.88 22.28 25.14 35.49 21.94 24.35 31.03 31.55
Enterprise Value to Free Cash Flow (EV/FCFF)
21.56 0.00 64.76 33.03 110.41 39.87 0.00 28.00 53.27 464.24 726.77
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.86 0.81 0.88 0.88 0.78 0.71 0.75 0.65 0.51 0.70 1.15
Long-Term Debt to Equity
0.86 0.71 0.88 0.69 0.70 0.67 0.75 0.64 0.47 0.66 1.08
Financial Leverage
0.40 0.43 0.48 0.52 0.59 0.50 0.50 0.52 0.39 0.36 0.35
Leverage Ratio
2.32 2.28 2.38 2.47 2.41 2.30 2.28 2.23 2.05 2.08 2.47
Compound Leverage Factor
2.18 2.14 2.23 2.32 2.21 2.14 2.16 2.12 1.94 1.94 2.32
Debt to Total Capital
46.18% 44.71% 46.70% 46.77% 43.97% 41.49% 42.94% 39.22% 33.98% 41.13% 53.43%
Short-Term Debt to Total Capital
0.00% 5.57% 0.01% 10.01% 4.92% 2.47% 0.04% 0.02% 2.77% 2.40% 3.23%
Long-Term Debt to Total Capital
46.18% 39.14% 46.68% 36.76% 39.05% 39.02% 42.90% 39.20% 31.21% 38.73% 50.20%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.66% 0.72% 0.71% 0.62% 0.80% 0.72% 0.69% 0.67% 0.63% 0.38% 0.33%
Common Equity to Total Capital
53.16% 54.57% 52.59% 52.61% 55.23% 57.79% 56.37% 60.11% 65.39% 58.49% 46.23%
Debt to EBITDA
2.18 2.10 2.12 1.79 1.86 1.98 1.92 1.53 1.45 1.81 2.25
Net Debt to EBITDA
0.81 1.28 1.07 1.15 1.39 1.09 1.42 1.05 0.89 0.93 0.59
Long-Term Debt to EBITDA
2.18 1.84 2.12 1.41 1.65 1.86 1.92 1.53 1.33 1.71 2.11
Debt to NOPAT
3.47 3.42 5.08 2.76 2.86 2.97 2.87 2.28 2.14 2.69 3.44
Net Debt to NOPAT
1.30 2.09 2.57 1.76 2.14 1.63 2.13 1.56 1.32 1.39 0.90
Long-Term Debt to NOPAT
3.47 3.00 5.08 2.17 2.54 2.79 2.87 2.28 1.96 2.53 3.23
Altman Z-Score
4.36 4.42 4.49 4.37 4.88 5.17 5.60 5.38 6.40 6.32 6.37
Noncontrolling Interest Sharing Ratio
1.13% 1.26% 1.31% 1.24% 1.31% 1.32% 1.22% 1.15% 1.02% 0.79% 0.69%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.82 2.20 2.95 1.87 1.97 2.38 2.43 2.42 2.17 2.37 2.98
Quick Ratio
2.84 1.54 2.12 1.26 1.24 1.60 1.51 1.52 1.36 1.62 2.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
739 -356 417 771 303 1,004 -718 1,704 1,156 188 233
Operating Cash Flow to CapEx
630.66% 586.61% 514.25% 364.10% 522.36% 602.80% 431.76% 574.99% 685.66% 428.03% 547.43%
Free Cash Flow to Firm to Interest Expense
10.82 -4.90 4.52 7.58 2.30 8.70 -6.22 13.27 8.29 0.87 0.63
Operating Cash Flow to Interest Expense
15.09 14.84 12.40 10.94 11.39 13.80 13.33 16.94 18.13 12.97 14.61
Operating Cash Flow Less CapEx to Interest Expense
12.70 12.31 9.99 7.94 9.21 11.51 10.25 13.99 15.48 9.94 11.94
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.77 0.79 0.76 0.82 0.79 0.74 0.81 0.84 0.79 0.80 0.80
Accounts Receivable Turnover
5.00 5.12 4.76 4.84 4.66 4.66 4.94 4.96 4.78 5.15 5.77
Inventory Turnover
4.41 4.77 4.62 4.74 4.41 4.28 4.45 4.31 3.98 4.28 4.88
Fixed Asset Turnover
9.28 9.52 9.18 9.69 8.77 8.37 9.76 10.61 9.97 10.06 11.50
Accounts Payable Turnover
6.28 6.71 6.05 6.28 6.38 5.97 6.15 6.56 6.37 6.36 6.51
Days Sales Outstanding (DSO)
73.03 71.24 76.73 75.44 78.28 78.27 73.94 73.53 76.31 70.81 63.26
Days Inventory Outstanding (DIO)
82.72 76.53 79.03 77.01 82.77 85.25 81.95 84.67 91.80 85.30 74.75
Days Payable Outstanding (DPO)
58.09 54.41 60.32 58.10 57.17 61.12 59.40 55.66 57.31 57.38 56.10
Cash Conversion Cycle (CCC)
97.65 93.36 95.44 94.34 103.87 102.41 96.49 102.55 110.80 98.73 81.90
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,375 5,610 5,890 6,412 7,369 7,667 10,057 10,363 11,235 13,606 17,884
Invested Capital Turnover
1.28 1.26 1.22 1.33 1.19 1.14 1.23 1.24 1.16 1.23 1.47
Increase / (Decrease) in Invested Capital
72 1,235 281 522 957 298 2,390 305 873 2,371 4,278
Enterprise Value (EV)
15,929 21,168 27,000 25,459 33,470 40,021 54,655 47,707 61,571 87,345 169,583
Market Capitalization
14,836 19,282 25,157 23,132 30,706 37,826 51,019 44,485 58,814 83,730 165,419
Book Value per Share
$10.51 $11.91 $13.07 $13.33 $15.28 $18.00 $10.54 $11.79 $13.95 $8.12 $10.96
Tangible Book Value per Share
$0.78 ($1.69) ($1.77) ($1.61) ($2.63) ($0.15) ($1.39) ($0.28) $0.70 $0.27 $0.49
Total Capital
6,092 6,734 7,586 7,635 8,203 9,318 11,179 11,672 12,764 16,742 29,012
Total Debt
2,814 3,011 3,543 3,571 3,607 3,867 4,800 4,578 4,337 6,886 15,502
Total Long-Term Debt
2,813 2,636 3,542 2,806 3,203 3,636 4,796 4,575 3,984 6,484 14,565
Net Debt
1,053 1,838 1,789 2,279 2,698 2,128 3,559 3,144 2,677 3,551 4,068
Capital Expenditures (CapEx)
163 184 223 306 288 264 357 378 369 658 982
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,082 1,158 1,324 1,593 1,573 1,679 2,274 2,372 2,376 2,669 2,967
Debt-free Net Working Capital (DFNWC)
2,842 2,331 3,078 2,885 2,482 3,417 3,515 3,806 4,036 6,004 14,402
Net Working Capital (NWC)
2,842 1,956 3,077 2,120 2,079 3,187 3,511 3,803 3,683 5,602 13,464
Net Nonoperating Expense (NNE)
38 47 37 75 96 89 81 92 83 118 206
Net Nonoperating Obligations (NNO)
1,096 1,887 1,847 2,348 2,773 2,215 3,678 3,268 2,809 3,750 4,375
Total Depreciation and Amortization (D&A)
172 217 227 300 312 308 396 393 406 573 922
Debt-free, Cash-free Net Working Capital to Revenue
19.42% 18.42% 18.88% 19.42% 19.13% 19.52% 20.91% 18.79% 18.93% 17.53% 12.85%
Debt-free Net Working Capital to Revenue
51.03% 37.08% 43.90% 35.17% 30.17% 39.74% 32.32% 30.15% 32.15% 39.44% 62.36%
Net Working Capital to Revenue
51.03% 31.11% 43.88% 25.85% 25.27% 37.06% 32.28% 30.13% 29.33% 36.80% 58.30%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.62 $0.00 $0.00 $0.00 $0.97 $1.01 $1.33 $1.60 $1.62 $2.01 $3.51
Adjusted Weighted Average Basic Shares Outstanding
1.24B 0.00 0.00 0.00 1.19B 1.19B 1.20B 1.19B 1.19B 1.20B 1.22B
Adjusted Diluted Earnings per Share
$0.60 $0.00 $0.00 $0.00 $0.94 $0.98 $1.27 $1.53 $1.56 $1.92 $3.34
Adjusted Weighted Average Diluted Shares Outstanding
1.27B 0.00 0.00 0.00 1.23B 1.23B 1.25B 1.24B 1.24B 1.26B 1.28B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.23B 0.00 0.00 0.00 1.19B 1.20B 1.20B 1.19B 1.20B 1.21B 1.23B
Normalized Net Operating Profit after Tax (NOPAT)
815 906 1,002 1,299 1,280 1,311 1,728 2,009 2,029 2,559 4,511
Normalized NOPAT Margin
14.63% 14.41% 14.29% 15.84% 15.56% 15.25% 15.89% 15.91% 16.16% 16.81% 19.53%
Pre Tax Income Margin
18.91% 18.15% 19.29% 19.37% 18.19% 17.75% 18.29% 19.55% 19.55% 19.79% 24.25%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
16.41 16.72 15.65 16.62 12.34 14.23 18.22 20.22 18.60 14.88 16.23
NOPAT to Interest Expense
11.86 12.11 7.56 12.71 9.55 11.28 14.48 15.64 14.54 11.79 12.27
EBIT Less CapEx to Interest Expense
14.02 14.19 13.24 13.61 10.16 11.94 15.13 17.27 15.95 11.85 13.56
NOPAT Less CapEx to Interest Expense
9.47 9.58 5.15 9.70 7.37 9.00 11.39 12.70 11.90 8.76 9.60
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
21.42% 21.56% 34.72% 22.34% 27.73% 25.76% 22.98% 25.42% 26.96% 25.72% 18.77%
Augmented Payout Ratio
53.65% 60.69% 128.26% 99.19% 79.42% 78.61% 64.58% 63.53% 57.04% 53.96% 34.22%

Quarterly Metrics And Ratios for Amphenol

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 1,229,214,930.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,229,214,930.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.76
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.91% 2.73% 9.49% 18.20% 26.24% 29.76% 47.74% 56.53% 53.37% 49.12% 58.39%
EBITDA Growth
-2.31% 4.85% 16.25% 16.37% 34.36% 37.47% 58.55% 94.19% 88.89% 80.85% 83.38%
EBIT Growth
-2.43% 4.63% 17.62% 14.14% 24.52% 39.51% 48.32% 98.44% 107.25% 81.98% 78.33%
NOPAT Growth
2.78% 0.05% 21.92% 14.99% 19.62% 46.33% 38.86% 108.15% 102.23% 59.83% 32.57%
Net Income Growth
3.56% 1.60% 24.69% 13.63% 17.48% 44.84% 34.82% 108.21% 106.13% 60.27% 26.75%
EPS Growth
3.56% 1.60% 22.54% 10.81% 17.07% 44.19% 31.82% 109.76% 102.08% 58.06% 24.14%
Operating Cash Flow Growth
7.31% 19.35% 12.60% 23.81% 13.90% 0.63% 27.59% 113.34% 108.92% 103.31% 46.62%
Free Cash Flow Firm Growth
132.85% -243.49% -164.94% -1,700.35% -1,372.89% -373.42% -4,122.94% 3.21% 12.77% -90.68% -183.88%
Invested Capital Growth
3.44% 8.42% 6.30% 26.45% 28.29% 21.10% 42.91% 24.90% 24.67% 31.44% 77.78%
Revenue Q/Q Growth
4.76% 4.01% -2.14% 10.85% 11.89% 6.91% 11.42% 17.45% 9.63% 3.95% 18.34%
EBITDA Q/Q Growth
5.94% 6.17% -1.34% 4.86% 22.32% 8.63% 13.79% 28.43% 18.98% 4.01% 15.38%
EBIT Q/Q Growth
5.74% 5.01% 0.04% 2.75% 15.36% 17.65% 6.35% 37.48% 20.48% 3.31% 4.22%
NOPAT Q/Q Growth
11.20% 0.02% 5.95% -2.42% 15.68% 22.36% 0.53% 46.27% 12.39% -3.29% -16.62%
Net Income Q/Q Growth
11.39% 0.17% 10.03% -4.22% 15.17% 23.50% -1.04% 47.92% 14.02% -3.98% -21.73%
EPS Q/Q Growth
11.39% 0.17% 4.82% -52.87% 17.07% 29.17% -6.45% 48.28% 12.79% 1.03% -26.53%
Operating Cash Flow Q/Q Growth
15.23% 36.19% -28.78% 10.78% 6.01% 20.33% -9.70% 85.23% 3.81% 17.09% -34.88%
Free Cash Flow Firm Q/Q Growth
33.10% -280.31% 71.44% -2,235.20% -5.87% 32.94% -154.72% 46.48% 4.59% -46.59% -279.22%
Invested Capital Q/Q Growth
0.84% 5.77% 0.07% 18.48% 2.30% -0.15% 18.09% 3.55% 2.11% 5.28% 59.72%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.77% 33.07% 33.44% 33.61% 33.60% 34.29% 34.17% 36.34% 38.09% 38.22% 36.75%
EBITDA Margin
24.01% 24.51% 24.71% 23.37% 25.55% 25.96% 26.52% 29.00% 31.47% 31.49% 30.70%
Operating Margin
20.56% 20.74% 21.03% 19.36% 20.29% 22.09% 21.30% 25.11% 27.48% 26.75% 24.04%
EBIT Margin
20.85% 21.05% 21.52% 19.95% 20.57% 22.63% 21.60% 25.29% 27.79% 27.62% 24.33%
Profit (Net Income) Margin
16.20% 15.60% 16.95% 14.65% 15.08% 17.42% 15.47% 19.48% 20.26% 18.72% 12.38%
Tax Burden Percent
81.82% 78.02% 83.30% 79.65% 78.57% 82.60% 77.29% 81.66% 76.49% 73.10% 57.32%
Interest Burden Percent
94.96% 95.00% 94.56% 92.18% 93.29% 93.15% 92.64% 94.34% 95.31% 92.71% 88.78%
Effective Tax Rate
18.18% 21.98% 16.70% 20.35% 21.43% 17.40% 22.71% 18.34% 23.51% 26.90% 42.68%
Return on Invested Capital (ROIC)
20.08% 18.81% 20.61% 17.31% 18.71% 22.36% 20.23% 25.76% 28.80% 28.68% 15.99%
ROIC Less NNEP Spread (ROIC-NNEP)
19.45% 18.18% 19.96% 16.54% 17.68% 21.27% 19.06% 24.52% 27.69% 27.35% 14.94%
Return on Net Nonoperating Assets (RNNOA)
8.40% 7.12% 7.01% 7.17% 6.87% 7.63% 8.14% 11.05% 10.61% 9.51% 12.31%
Return on Equity (ROE)
28.48% 25.93% 27.62% 24.48% 25.58% 29.99% 28.37% 36.81% 39.41% 38.20% 28.31%
Cash Return on Invested Capital (CROIC)
16.04% 10.70% 13.43% -4.89% -5.73% 1.51% -14.97% 0.44% 4.44% 1.48% -34.56%
Operating Return on Assets (OROA)
16.85% 16.59% 17.21% 15.80% 16.56% 18.15% 18.30% 21.51% 24.95% 22.12% 19.38%
Return on Assets (ROA)
13.09% 12.30% 13.56% 11.60% 12.14% 13.97% 13.10% 16.57% 18.19% 14.99% 9.86%
Return on Common Equity (ROCE)
28.17% 25.66% 27.34% 24.26% 25.35% 29.76% 28.14% 36.54% 39.13% 37.93% 28.09%
Return on Equity Simple (ROE_SIMPLE)
24.47% 0.00% 23.47% 23.39% 23.18% 0.00% 25.57% 27.83% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
538 538 570 557 644 788 792 1,159 1,302 1,259 1,050
NOPAT Margin
16.82% 16.18% 17.52% 15.42% 15.94% 18.25% 16.46% 20.50% 21.02% 19.56% 13.78%
Net Nonoperating Expense Percent (NNEP)
0.63% 0.63% 0.65% 0.77% 1.03% 1.09% 1.17% 1.24% 1.11% 1.33% 1.06%
Return On Investment Capital (ROIC_SIMPLE)
- 4.23% - - - 4.71% 4.52% 5.90% 6.30% 4.34% 3.20%
Cost of Revenue to Revenue
67.23% 66.93% 66.56% 66.39% 66.40% 65.71% 65.83% 63.66% 61.91% 61.78% 63.25%
SG&A Expenses to Revenue
11.93% 11.85% 12.41% 12.31% 12.18% 11.92% 11.96% 11.02% 10.61% 10.73% 11.17%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.21% 12.33% 12.41% 14.25% 13.31% 12.20% 12.87% 11.23% 10.61% 11.47% 12.71%
Earnings before Interest and Taxes (EBIT)
667 701 701 720 831 977 1,039 1,429 1,722 1,779 1,854
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
768 816 805 844 1,032 1,121 1,276 1,638 1,949 2,028 2,339
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.32 7.05 7.94 9.01 8.30 8.55 7.71 10.37 12.07 12.33 11.11
Price to Tangible Book Value (P/TBV)
92.32 140.27 86.61 0.00 0.00 253.19 0.00 0.00 225.71 277.41 0.00
Price to Revenue (P/Rev)
3.98 4.68 5.37 6.04 5.51 5.50 4.73 6.35 7.20 7.16 6.00
Price to Earnings (P/E)
26.05 30.51 34.11 38.83 36.08 34.54 30.40 37.57 39.54 38.74 34.78
Dividend Yield
1.01% 0.86% 0.75% 0.65% 0.76% 0.79% 0.92% 0.67% 0.53% 0.55% 0.66%
Earnings Yield
3.84% 3.28% 2.93% 2.58% 2.77% 2.90% 3.29% 2.66% 2.53% 2.58% 2.88%
Enterprise Value to Invested Capital (EV/IC)
4.93 5.48 6.35 6.39 6.05 6.42 5.29 7.48 9.15 9.48 5.94
Enterprise Value to Revenue (EV/Rev)
4.20 4.90 5.56 6.36 5.79 5.74 5.07 6.61 7.41 7.34 6.55
Enterprise Value to EBITDA (EV/EBITDA)
17.66 20.52 22.91 26.34 23.58 22.98 19.90 24.54 25.96 24.61 21.32
Enterprise Value to EBIT (EV/EBIT)
20.41 23.73 26.43 30.53 27.93 27.05 23.83 29.08 30.06 28.41 25.00
Enterprise Value to NOPAT (EV/NOPAT)
25.79 30.35 33.47 38.63 35.70 34.13 30.57 36.76 38.45 37.59 35.44
Enterprise Value to Operating Cash Flow (EV/OCF)
21.87 24.35 27.48 31.26 29.35 31.03 28.52 33.32 34.53 31.55 29.59
Enterprise Value to Free Cash Flow (EV/FCFF)
31.22 53.27 48.68 0.00 0.00 464.24 0.00 1,884.75 228.84 726.77 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.54 0.51 0.49 0.60 0.58 0.70 0.69 0.70 0.64 1.15 1.33
Long-Term Debt to Equity
0.50 0.47 0.41 0.56 0.53 0.66 0.66 0.61 0.57 1.08 1.18
Financial Leverage
0.43 0.39 0.35 0.43 0.39 0.36 0.43 0.45 0.38 0.35 0.82
Leverage Ratio
2.12 2.05 1.99 2.03 2.02 2.08 2.07 2.14 2.11 2.47 2.66
Compound Leverage Factor
2.01 1.95 1.88 1.87 1.89 1.93 1.92 2.02 2.01 2.29 2.36
Debt to Total Capital
35.09% 33.98% 32.96% 37.54% 36.53% 41.13% 40.86% 41.00% 39.02% 53.43% 57.09%
Short-Term Debt to Total Capital
2.91% 2.77% 5.76% 2.79% 2.69% 2.40% 2.00% 4.76% 4.54% 3.23% 6.42%
Long-Term Debt to Total Capital
32.19% 31.21% 27.21% 34.75% 33.85% 38.73% 38.86% 36.24% 34.49% 50.20% 50.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.67% 0.63% 0.64% 0.49% 0.50% 0.38% 0.41% 0.41% 0.42% 0.33% 0.35%
Common Equity to Total Capital
64.24% 65.39% 66.40% 61.97% 62.97% 58.49% 58.73% 58.59% 60.56% 46.23% 42.56%
Debt to EBITDA
1.45 1.45 1.38 1.68 1.57 1.81 1.68 1.59 1.35 2.25 2.36
Net Debt to EBITDA
0.86 0.89 0.75 1.28 1.12 0.93 1.29 0.95 0.70 0.59 1.78
Long-Term Debt to EBITDA
1.33 1.33 1.14 1.56 1.45 1.71 1.60 1.41 1.19 2.11 2.09
Debt to NOPAT
2.12 2.14 2.02 2.47 2.37 2.69 2.58 2.38 2.00 3.44 3.92
Net Debt to NOPAT
1.26 1.32 1.10 1.88 1.69 1.39 1.98 1.43 1.03 0.90 2.96
Long-Term Debt to NOPAT
1.94 1.96 1.67 2.28 2.20 2.53 2.45 2.11 1.76 3.23 3.48
Altman Z-Score
5.54 6.03 6.88 6.65 6.27 5.97 5.38 6.72 7.97 5.99 4.61
Noncontrolling Interest Sharing Ratio
1.09% 1.02% 1.00% 0.90% 0.89% 0.79% 0.81% 0.73% 0.73% 0.69% 0.76%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.33 2.17 2.06 2.02 1.99 2.37 1.99 2.02 2.07 2.98 1.71
Quick Ratio
1.48 1.36 1.30 1.20 1.21 1.62 1.22 1.34 1.41 2.37 1.17
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
185 -334 -95 -2,230 -2,361 -1,583 -4,033 -2,158 -2,059 -3,019 -11,448
Operating Cash Flow to CapEx
833.02% 816.49% 639.13% 486.88% 308.37% 425.46% 414.58% 479.46% 576.11% 698.66% 386.32%
Free Cash Flow to Firm to Interest Expense
5.52 -9.55 -2.51 -39.61 -42.38 -23.66 -52.71 -26.68 -25.52 -23.27 -55.06
Operating Cash Flow to Interest Expense
18.40 24.05 15.73 11.80 12.64 12.66 10.00 17.51 18.23 13.28 5.39
Operating Cash Flow Less CapEx to Interest Expense
16.19 21.11 13.27 9.37 8.54 9.69 7.59 13.86 15.06 11.38 4.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.81 0.79 0.80 0.79 0.81 0.80 0.85 0.85 0.90 0.80 0.80
Accounts Receivable Turnover
4.78 4.78 5.23 5.05 4.99 5.15 5.23 5.28 5.47 5.77 5.29
Inventory Turnover
4.04 3.98 4.04 4.07 4.05 4.28 4.38 4.44 4.57 4.88 4.64
Fixed Asset Turnover
10.33 9.97 10.05 9.59 9.76 10.06 10.60 10.49 11.00 11.50 11.40
Accounts Payable Turnover
6.39 6.37 7.04 6.78 6.29 6.36 6.51 6.31 6.36 6.51 6.10
Days Sales Outstanding (DSO)
76.29 76.31 69.85 72.21 73.11 70.81 69.85 69.11 66.78 63.26 69.00
Days Inventory Outstanding (DIO)
90.31 91.80 90.28 89.73 90.12 85.30 83.31 82.25 79.85 74.75 78.64
Days Payable Outstanding (DPO)
57.10 57.31 51.88 53.85 58.03 57.38 56.11 57.86 57.39 56.10 59.87
Cash Conversion Cycle (CCC)
109.50 110.80 108.25 108.10 105.21 98.73 97.06 93.50 89.23 81.90 87.77
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,622 11,235 11,243 13,320 13,627 13,606 16,067 16,637 16,988 17,884 28,565
Invested Capital Turnover
1.19 1.16 1.18 1.12 1.17 1.23 1.23 1.26 1.37 1.47 1.16
Increase / (Decrease) in Invested Capital
353 873 666 2,787 3,005 2,371 4,825 3,317 3,361 4,278 12,498
Enterprise Value (EV)
52,315 61,571 71,334 85,133 82,447 87,345 85,001 124,364 155,355 169,583 169,592
Market Capitalization
49,675 58,814 68,905 80,925 78,471 83,730 79,435 119,448 151,089 165,419 155,311
Book Value per Share
$13.17 $13.95 $14.47 $14.95 $7.85 $8.12 $8.51 $9.52 $10.25 $10.96 $11.37
Tangible Book Value per Share
$0.90 $0.70 $1.33 ($0.98) ($0.12) $0.27 ($0.80) ($0.10) $0.55 $0.49 ($7.30)
Total Capital
12,230 12,764 13,074 14,490 15,011 16,742 17,539 19,662 20,674 29,012 32,840
Total Debt
4,292 4,337 4,309 5,439 5,484 6,886 7,167 8,062 8,067 15,502 18,749
Total Long-Term Debt
3,936 3,984 3,557 5,035 5,081 6,484 6,816 7,126 7,130 14,565 16,639
Net Debt
2,558 2,677 2,346 4,137 3,901 3,551 5,495 4,836 4,179 4,068 14,166
Capital Expenditures (CapEx)
74 103 94 136 228 199 185 296 255 247 290
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,486 2,376 2,408 2,618 2,691 2,669 3,221 3,405 3,450 2,967 3,936
Debt-free Net Working Capital (DFNWC)
4,220 4,036 4,371 3,920 4,274 6,004 4,893 6,631 7,338 14,402 8,519
Net Working Capital (NWC)
3,865 3,683 3,619 3,516 3,871 5,602 4,542 5,694 6,400 13,464 6,409
Net Nonoperating Expense (NNE)
20 19 18 28 35 36 48 58 47 54 107
Net Nonoperating Obligations (NNO)
2,684 2,809 2,478 4,270 4,100 3,750 5,695 5,037 4,381 4,375 14,473
Total Depreciation and Amortization (D&A)
101 115 104 124 201 144 236 209 228 249 486
Debt-free, Cash-free Net Working Capital to Revenue
19.94% 18.93% 18.76% 19.55% 18.91% 17.53% 19.20% 18.09% 16.45% 12.85% 15.19%
Debt-free Net Working Capital to Revenue
33.85% 32.15% 34.05% 29.27% 30.03% 39.44% 29.16% 35.24% 34.98% 62.36% 32.89%
Net Working Capital to Revenue
31.00% 29.33% 28.19% 26.25% 27.20% 36.80% 27.07% 30.26% 30.51% 58.30% 24.74%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.43 $0.22 $0.46 $0.44 $0.50 $0.62 $0.61 $0.90 $1.02 $0.98 $0.76
Adjusted Weighted Average Basic Shares Outstanding
1.20B 2.39B 1.20B 1.20B 1.20B 1.20B 1.21B 1.22B 1.22B 1.22B 1.23B
Adjusted Diluted Earnings per Share
$0.42 $0.22 $0.44 $0.41 $0.48 $0.62 $0.58 $0.86 $0.97 $0.98 $0.72
Adjusted Weighted Average Diluted Shares Outstanding
1.24B 2.48B 1.26B 1.26B 1.27B 1.26B 1.27B 1.27B 1.28B 1.28B 1.29B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.22 $0.00 $0.00 $0.00 $0.62 $0.00 $0.00 $0.00 $0.98 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.20B 1.20B 1.20B 1.20B 1.21B 1.21B 1.21B 1.22B 1.22B 1.23B 1.23B
Normalized Net Operating Profit after Tax (NOPAT)
538 538 570 612 644 788 792 1,168 1,302 1,259 1,050
Normalized NOPAT Margin
16.82% 16.18% 17.52% 16.96% 15.94% 18.25% 16.46% 20.68% 21.02% 19.56% 13.78%
Pre Tax Income Margin
19.80% 20.00% 20.35% 18.39% 19.19% 21.08% 20.01% 23.86% 26.49% 25.61% 21.60%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
19.85 20.01 18.39 12.79 14.91 14.61 13.59 17.66 21.33 13.71 8.92
NOPAT to Interest Expense
16.02 15.38 14.97 9.89 11.56 11.78 10.35 14.32 16.13 9.71 5.05
EBIT Less CapEx to Interest Expense
17.65 17.07 15.93 10.37 10.82 11.63 11.18 14.01 18.17 11.81 7.52
NOPAT Less CapEx to Interest Expense
13.81 12.44 12.51 7.46 7.46 8.80 7.94 10.67 12.97 7.81 3.65
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
26.39% 26.96% 25.83% 26.16% 25.49% 25.72% 26.42% 23.33% 21.21% 18.77% 20.32%
Augmented Payout Ratio
59.69% 57.04% 53.90% 55.14% 54.50% 53.96% 53.62% 44.73% 38.41% 34.22% 35.02%

Financials Breakdown Chart

Key Financial Trends

Amphenol (NYSE: APH) continues to show strong top‑line growth and improving profitability in 2025, supported by healthy cash flow generation. While the company is leveraging debt to fund expansion, the core business appears to be improving margin and producing meaningful free cash flow.

  • Revenue growth and scale: Q4 2025 operating revenue rose to 6.439B, up from 4.318B in Q4 2024 (roughly a 49% year‑over‑year increase), signaling solid top‑line momentum.
  • Gross margin expansion: Gross margin was about 38% in Q4 2025 versus about 34% in Q4 2024, indicating improved pricing/mix or cost discipline.
  • Profitability improvement: Net income to common reached 1.196B in Q4 2025 with earnings per share of 0.98, up from 0.746B and 0.62 EPS in Q4 2024.
  • stronger operating cash flow: Net cash from continuing operating activities was 1.722B in Q4 2025, well above the 0.847B level in Q4 2024, highlighting better cash generation from operations.
  • Dividend per share rising: Cash dividends per share increased to 0.17 in Q4 2025, up from 0.165 in Q4 2024, signaling ongoing shareholder return.
  • Solid balance sheet size and growth: By Q3 2025, total assets were about 27.14B with total equity around 12.5B, illustrating a growing and balanced balance sheet to support scale.
  • Healthy near‑term liquidity: Cash and equivalents were around 3.8B in Q3 2025, providing a cushion for operations and investments.
  • Significant debt financing activity in 2025: The company executed sizable debt issuances around 7.49B in mid/late 2025 to fund growth, indicating a shift toward higher leverage to accelerate expansion.
  • Rising leverage and interest costs: Long‑term debt rose to about 7.13B by Q3 2025, with 2025 quarterly interest expense around 129.7M (vs ~118.4M in the prior year), suggesting higher interest costs as leverage increases.
  • Investing cash flow remains negative due to capital investments: Net cash from investing activities in Q4 2025 was -1.503B, reflecting ongoing capex and acquisitions that weigh on near‑term cash, even as operating cash flow grows.
05/11/26 08:34 AM ETAI Generated. May Contain Errors.

Amphenol Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amphenol's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Amphenol's net income appears to be on an upward trend, with a most recent value of $4.31 billion in 2025, rising from $772.30 million in 2015. The previous period was $2.44 billion in 2024. View Amphenol's forecast to see where analysts expect Amphenol to go next.

Amphenol's total operating income in 2025 was $5.87 billion, based on the following breakdown:
  • Total Gross Profit: $8.52 billion
  • Total Operating Expenses: $2.65 billion

Over the last 10 years, Amphenol's total revenue changed from $5.57 billion in 2015 to $23.09 billion in 2025, a change of 314.7%.

Amphenol's total liabilities were at $22.73 billion at the end of 2025, a 96.2% increase from 2024, and a 443.7% increase since 2015.

In the past 10 years, Amphenol's cash and equivalents has ranged from $891.20 million in 2019 to $11.13 billion in 2025, and is currently $11.13 billion as of their latest financial filing in 2025.

Over the last 10 years, Amphenol's book value per share changed from 10.51 in 2015 to 10.96 in 2025, a change of 4.3%.



Financial statements for NYSE:APH last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners